Literature DB >> 9240427

Cigarette smoke extract inhibits plasma paraoxonase activity by modification of the enzyme's free thiols.

E Nishio1, Y Watanabe.   

Abstract

Cigarette smoking is associated with an increased incidence of premature atherosclerosis. Minimal information is available at the molecular level concerning the mechanism of action of cigarette smoke. Recent work has shown that paraoxonase (PON) protects low density lipoprotein against oxidation by Cu2+. The goal of the present study was to investigate the effect of cigarette smoke extract (CSE) on human plasma paraoxonase activity. The activity of paraoxonase was inhibited by the CSE in a dose- and time-dependent manner. The inhibition of PON activity by the CSE was reversed by the addition of glutathione or N-acetyl cysteine. Furthermore, we tested to see whether sulfhydryl compounds prevented the inhibition of PON activity caused by CSE. Sulfhydryl compounds prevented the inhibition of PON activity caused by CSE. But any amino compounds, such as N-acetyl lysine, N-acetyl arginine and aminoguanidine, failed to protect PON activity, indicating a specificity with regard to the ability of free thiols to buffer the deleterious components of CSE which inhibited PON activity. The observed inhibition of PON activity by CSE may account for the increased incidence of cardiovascular disease known to be present in smokers through the oxidative process of low density lipoprotein and its subsequent uptake by macrophage.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9240427     DOI: 10.1006/bbrc.1997.6961

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  29 in total

Review 1.  Pharmacogenetics of paraoxonase activity: elucidating the role of high-density lipoprotein in disease.

Authors:  Daniel Seung Kim; Judit Marsillach; Clement E Furlong; Gail P Jarvik
Journal:  Pharmacogenomics       Date:  2013-09       Impact factor: 2.533

Review 2.  Paraoxonases: metabolic role and pharmacological projection.

Authors:  Carlos Moya; Salvador Máñez
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-02-06       Impact factor: 3.000

Review 3.  CYP/PON genetic variations as determinant of organophosphate pesticides toxicity.

Authors:  Gurpreet Kaur; A K Jain; Sandeep Singh
Journal:  J Genet       Date:  2017-03       Impact factor: 1.166

4.  Paraoxonase 1, agricultural organophosphate exposure, and Parkinson disease.

Authors:  Angelika D Manthripragada; Sadie Costello; Myles G Cockburn; Jeff M Bronstein; Beate Ritz
Journal:  Epidemiology       Date:  2010-01       Impact factor: 4.822

5.  Paraoxonase 1 polymorphisms and risk of myocardial infarction in women and men.

Authors:  Kenneth J Mukamal; Jennifer K Pai; Majken K Jensen; Eric B Rimm
Journal:  Circ J       Date:  2009-05-15       Impact factor: 2.993

6.  Serum paraoxonase 1 activity is decreased in thyroid dysfunction.

Authors:  F Azizi; F Raiszadeh; M Solati; A Etemadi; M Rahmani; M Arabi
Journal:  J Endocrinol Invest       Date:  2003-08       Impact factor: 4.256

7.  Paraoxonase: Its antiatherogenic role in chronic renal failure.

Authors:  M Prakash; N M Phani; R Kavya; M Supriya
Journal:  Indian J Nephrol       Date:  2010-01

8.  Lower paraoxonase 1 activity in Tunisian bipolar I patients.

Authors:  Asma Ezzaher; Dhouha Haj Mouhamed; Anwar Mechri; Manel Araoud; Fadoua Neffati; Wahiba Douki; Lotfi Gaha; Mohamed Fadhel Najjar
Journal:  Ann Gen Psychiatry       Date:  2010-10-21       Impact factor: 3.455

9.  Racial differences in paraoxonase-1 (PON1): a factor in the health of southerners?

Authors:  Kimberly A Davis; J Allen Crow; Howard W Chambers; Edward C Meek; Janice E Chambers
Journal:  Environ Health Perspect       Date:  2009-03-12       Impact factor: 9.031

10.  A common haplotype within the PON1 promoter region is associated with sporadic ALS.

Authors:  John E Landers; Lijia Shi; Ting-Jan Cho; Jonathan D Glass; Christopher E Shaw; P Nigel Leigh; Frank Diekstra; Meraida Polak; Ildefonso Rodriguez-Leyva; Stephan Niemann; Bryan J Traynor; Diane McKenna-Yasek; Peter C Sapp; Ammar Al-Chalabi; Anne-Marie A Wills; Robert H Brown
Journal:  Amyotroph Lateral Scler       Date:  2008-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.